A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
一项前瞻性生物标志物分析,研究了阿洛西地布序贯阿糖胞苷和米托蒽醌治疗MCL-1依赖性复发/难治性急性髓系白血病的效果。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-021-00568-3
Zeidner, Joshua F; Lin, Tara L; Vigil, Carlos E; Fine, Gil; Yair Levy, M; Nazha, Aziz; Esteve, Jordi; Lee, Daniel J; Yee, Karen; Dalovisio, Andrew; Wang, Eunice S; Bergua Burgues, Juan M; Schriber, Jeffrey; Litzow, Mark R; Frankfurt, Olga; Castillo, Teresa Bernal Del; Bhatt, Vijaya Raj; Bhatnagar, Bhavana; Mehta, Priyanka; Dillon, Richard; Vicente, Maria Vidriales; Anthony, Stephen; Bearss, David; Montesinos, Pau; Douglas Smith, B